Kamel Abou Hussein, Medical Oncologist, Director of Breast Cancer Clinical Trials, and Co-Director of the Janet Knowles Breast Cancer Center at MD Anderson Cancer Center at Cooper, shared a post on LinkedIn:
“If you’re attending the 2026 ASCO Annual Meeting, I invite you to join us for an engaging satellite symposium:
Hot Seat: Which Agent, and When? Integrating Next-Generation Endocrine Strategies Into HR+/HER2- Breast Cancer.
May 31, 2026, 6:30 PM – 8:00 PM CDT at Sheraton Grand Chicago Riverwalk, 4th Floor, Chicago 6.
I’m honored to participate alongside an outstanding faculty:
- Ruta D. Rao, MD (Program Chair)
- Jame Abraham, MD, FACP
- Paolo Tarantino, MD, PhD
- Kamel Abou Hussein, MD
We look forward to discussing evolving endocrine treatment strategies and practical considerations in the management of HR+/HER2- breast cancer.”
Other articles featuring Kamel Abou Hussein on OncoDaily.